Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Influence of Pretransplant Restrictive Lung Disease on Allogeneic Hematopoietic Cell Transplantation Outcomes
Biology of Blood and Marrow Transplantation, 09/29/09
Ramirez–Sarmiento A et al. – These outcomes occurring in the absence of radiographically apparent abnormalities may be related to respiratory muscle weakness. The findings suggest that pulmonary restriction should be considered as a risk factor for poor outcomes after transplant.
Related Articles
Effects of pulmonary rehabilitation in patients with restrictive lung diseases
Chest, 10/29/09
Relevance Score: 80%
Lung involvement in patients with primary Sjögrens syndrome: What are the predictors?
Rheumatology International, 10/26/09
Relevance Score: 80%
Angiogenic and Angiostatic Chemokines in Idiopathic Pulmonary Fibrosis and Granulomatous Lung Disease
Respiration, 10/14/09
Relevance Score: 80%
Minor Salivary Gland Biopsy To Detect Primary Sjogren Syndrome in Patients With Interstitial Lung Disease
Chest, 10/09/09
Relevance Score: 80%
Emerging profile of cetuximab in non-small cell lung cancer
Lung Cancer, 10/05/09
Relevance Score: 79%
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Differential Destruction of Stem Cells: Implications for Targeted Cancer Stem Cell Therapy
Cancer Research, 12/19/09
Can antigen-specific regulatory T cells protect against graft vs. host disease and spare anti-malignancy alloresponse
Haematologica, 12/19/09
Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis
Annals of Hematology, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


